Diagnosis Prostate Cancer via Molecular Computed Tomography Imaging based on Targeted Gold Nanoparticles.
The current study demonstrates that synthesized TAuNPs are emerged as a contrast agent, which is targeted for molecular CT imaging of prostate cancer cells, expressing the gonadotropin-releasing hormone (GnRH) receptor.
Authors
- Sara Khademi (ORCID: https://orcid.org/0000-0001-9823-8014)
- Alireza Montazerabadi (ORCID: https://orcid.org/0000-0001-6756-0318)
- Farzaneh Ghorbani (ORCID: https://orcid.org/0000-0003-4191-9868)
- Samaneh Abbasi
- Fatemeh Rabani
Institutions
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- PubMed
- Published
- 2025-03-22
- DOI
- https://doi.org/10.22074/cellj.2025.2035821.1624
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00